Patent · US Active

Vaporized medicants and methods of use

US11622985B2 · kind B2 · utility

0Cited by
13References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 12, 2021
Grant dateApr 11, 2023
Priority date
Expiry dateApr 25, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2236/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method and formulation for delivering a motion sickness antidote in a vaporized state using low temperatures to vaporize the formulation. The formulation contains an inert non-reactive compound that lowers the heat of vaporization of the formulation, and the motion sickness antidote. The formulation may optionally contain glycerin, alcohol, and/or water. Examples of inert non-reactive compounds that can sufficiently lower the heat of vaporization of the formulation include propylene glycol, vegetable glycerin and polysorbate. The formulation can be vaporized using a hand-held low temperature vaporizer or atomizer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.